MedTrace Logo

The International SubcutaneouS Implantable Cardioverter Defibrillator Registry (iSuSI)

NCT05390047 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 4000

Last updated 2024-07-01

No results posted yet for this study

Summary

The entirely subcutaneous implantable defibrillator (S-ICD) (Emblem, Boston Scientific, Marlborough, MA, USA) was introduced as a new therapeutic alternative to the conventional transvenous ICD in 2009 and implantations are rapidly expanding since then.1 Implantation of the S-ICD seems to reduce implant-related perioperative complications such as pneumothorax, hematoma and cardiac tamponade.

The aim of this multicenter registry is thus to assess the outcome of patients following an S-ICD implantation in a real-world setting.

Conditions

Sponsors & Collaborators

  • Prof. Jürgen Kuschyk, M.D

    collaborator UNKNOWN

  • Giovanni Forleo, M.D.

    collaborator UNKNOWN

  • Mauro Biffi, M.D.

    collaborator UNKNOWN

  • University of Luebeck

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
99 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-07-01
Primary Completion
2025-06-01
Completion
2025-09-30

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05390047 on ClinicalTrials.gov